SCHEMBL3607451

SCHEMBL3607451

O=C(O)c1ccc(-c2cc(-c3nnn[nH]3)c(-c3ccc(C(=O)O)cc3)s2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
CSNK2A1 P68400 8/20 0.40
HDAC1 Q13547 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
CSNK2A2 P19784 7/20 0.38
CSNK2B P67870 1/20 0.38
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
TTR P02766 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35
HSD17B1 P14061 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3595152 0.88 PRF1 (0.42) ESR1ESR2MAP2K4MAPK1MAPKAPK3
SCHEMBL3606907 0.86 HDAC1 (0.44) HDAC1HDAC6KDM4EALDH1A1HSD17B1
SCHEMBL3604357 0.83 ESR1 (0.61) ESR1ESR2HSD17B1
SCHEMBL16062588 0.81 ESR1 (0.41) ESR1ESR2KDM4EALDH1A1HSD17B1
SCHEMBL3601024 0.81 MAPK14 (0.42) ESR1ESR2KDM4EHSD17B1
SCHEMBL3612213 0.79 CDC7 (0.40) ESR1ESR2KDM4E
SCHEMBL2819906 0.78 KDM4E (0.50) CSNK2A1CSNK2A2CSNK2BKDM4EALDH1A1
SCHEMBL3596461 0.78 HSD17B1 (0.41) CSNK2A1HSD17B1MAP2K4MAPK1
SCHEMBL3606893 0.77 PDGFRB (0.44) ESR1ESR2KDM4EALDH1A1MAPK1
SCHEMBL3599763 0.77 PTPN1 (0.47) HDAC6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8835476-B2 Synthesis of novel antimicrobials WU FAN (CA) 2014-09-16 US disclosed
US-20100076028-A1 Design and Synthesis of Novel Antimicrobials WU FAN 2010-03-25 US disclosed
WO-2006092059-A1 DESIGN AND SYNTHESIS OF NOVEL ANTIMICROBIALS WU FAN (CA) 2006-09-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100076028-A1 Design and Synthesis of Novel Antimicrobials MLX, LPXN, TPX2 ESR1 1779/4885ESR2 2227/4885CSNK2A1 1942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.